Jay S. Schneider,John J. Koleng,Robert Florentine,David W. Anderson
申请号：
US14726817
公开号：
US20160082026A1
申请日:
2015.06.01
申请国别(地区):
US
年份:
2016
代理人:
摘要：
A transmucosal formulation comprising a ganglioside and a mucosal absorption enhancer, as well as a method of treating or preventing Parkinsons disease in a human patient in need thereof comprising parenterally administering such a transmucosal formulation to said patient.
